Literature DB >> 19734027

Pathology of soft tissue sarcomas.

K Thway1.   

Abstract

Sarcomas are a rare, complex group of childhood and adult neoplasms with differentiation towards mesenchymal tissue, which may arise almost anywhere in the body. Although pathologically diverse, they frequently exhibit similar clinical presentations and radiological features. Correct histopathological diagnosis is therefore crucial, but there is overlap between histological patterns of malignant tumours, between benign and malignant lesions, and with non-mesenchymal tumours. Immunohistochemistry and molecular genetic techniques, the latter to detect tumour-specific alterations, add significantly to histological interpretation, but several groups of tumours still lack reliable immunohistochemical markers or reproducible genetic changes. The classification of sarcomas is incomplete and continues to evolve, and although the biology of many remains relatively poorly understood, our increasing insight into molecular events occurring in these tumours is certain to aid future diagnosis and therapy. This paper aims to give a broad overview of several of the main soft tissue sarcomas from a clinicopathological perspective, discussing laboratory diagnosis and the use and limitations of ancillary investigations, including recent developments in molecular diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734027     DOI: 10.1016/j.clon.2009.07.016

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  14 in total

1.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

2.  Comparison between MRI with spin-echo echo-planar diffusion-weighted sequence (DWI) and histology in the diagnosis of soft-tissue tumours.

Authors:  E Genovese; A Canì; S Rizzo; M G Angeretti; A Leonardi; C Fugazzola
Journal:  Radiol Med       Date:  2011-03-19       Impact factor: 3.469

3.  An Unusual Case of Peritoneal Carcinomatosis.

Authors:  Stijn Hillewaere; Linde Stessens; Kurt Van der Speeten
Journal:  Case Rep Oncol       Date:  2010-09-09

4.  A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study.

Authors:  Elena Fountzilas; Andrew D Kelly; Antonio R Perez-Atayde; Jeffrey Goldsmith; Panagiotis A Konstantinopoulos; Nancy Francoeur; Mick Correll; Renee Rubio; Lan Hu; Mark C Gebhardt; John Quackenbush; Dimitrios Spentzos
Journal:  BMC Genomics       Date:  2012-07-23       Impact factor: 3.969

5.  Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.

Authors:  Thomas K Kilvaer; Andrej Valkov; Sveinung Sorbye; Eivind Smeland; Roy M Bremnes; Lill-Tove Busund; Tom Donnem
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

6.  A Low-Grade Fibromyxoid Sarcoma of the Internal Abdominal Oblique Muscle.

Authors:  Masakazu Hashimoto; Kei Koide; Michinori Arita; Koji Kawaguchi; Yoshihiro Mikuriya; Jun Iwata; Toshiyuki Iwamoto
Journal:  Case Rep Surg       Date:  2016-05-10

7.  HMGB1-mediated autophagy decreases sensitivity to oxymatrine in SW982 human synovial sarcoma cells.

Authors:  Yongsong Cai; Peng Xu; Le Yang; Ke Xu; Jialin Zhu; Xiaoqing Wu; Congshan Jiang; Qiling Yuan; Bo Wang; Yuanbo Li; Yusheng Qiu
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

8.  Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.

Authors:  Yoshinori Imura; Takaaki Nakai; Shutaro Yamada; Hidetatsu Outani; Satoshi Takenaka; Kenichiro Hamada; Nobuhito Araki; Kazuyuki Itoh; Hideki Yoshikawa; Norifumi Naka
Journal:  Cancer Sci       Date:  2016-12-19       Impact factor: 6.716

Review 9.  Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies.

Authors:  Daniela Augsburger; Peter J Nelson; Thomas Kalinski; Andrej Udelnow; Thomas Knösel; Monika Hofstetter; Ji Wei Qin; Yan Wang; Arvid Sen Gupta; Susanne Bonifatius; Minglun Li; Christiane J Bruns; Yue Zhao
Journal:  Oncotarget       Date:  2017-08-10

10.  Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability.

Authors:  Kim M Boerkamp; Gerard R Rutteman; Marja J L Kik; Jolle Kirpensteijn; Christoph Schulze; Guy C M Grinwis
Journal:  Cancers (Basel)       Date:  2012-12-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.